About this trial
The goal of this observational study is knowledge of Prevalence of throid abnormalities in patients with acute coronary syndrome And prognostic effects of thyroid abnormalities in patients with acute coronary syndrome as early detection and management of thyroid abnormalities can improve clinical outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with ACS: (STEMI_NSTEMI)
Disqualifiers
1-patients with cardiogenic shock. 2- patients with other endocrinal diseases. 3- patients on dialysis. 4-patients with Acute malignancy. 5-patient with thyroid diseases on treatment. 6- patients with liver diseases. 7-patients with Any autoimmune diseases
Trial population
Patient with ACS and thyroid abnormalities. patients with ACS and euthyroid.
Trial design
Other
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Prevalence of thyroid abnormalities in patients with acute coronary syndrome .
Prevalence of thyroid abnormalities in patients with acute coronary syndrome .
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: